Global COPD Medication Market Size, Status and Forecast 2024-2031

Report ID: 919767 | Published Date: Jan 2025 | No. of Page: 97 | Base Year: 2024 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global COPD Medication Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Short-Acting Bronchodilator
        1.2.3 Corticosteroids
        1.2.4 Methylxanthines
        1.2.5 Long-Acting Bronchodilators
        1.2.6 Combination Drugs
    1.3 Market by Application
        1.3.1 Global COPD Medication Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Pharmacy
        1.3.5 Online Pharmacy
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global COPD Medication Market Perspective (2016-2027)
    2.2 COPD Medication Growth Trends by Regions
        2.2.1 COPD Medication Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 COPD Medication Historic Market Share by Regions (2016-2021)
        2.2.3 COPD Medication Forecasted Market Size by Regions (2022-2027)
    2.3 COPD Medication Industry Dynamic
        2.3.1 COPD Medication Market Trends
        2.3.2 COPD Medication Market Drivers
        2.3.3 COPD Medication Market Challenges
        2.3.4 COPD Medication Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top COPD Medication Players by Revenue
        3.1.1 Global Top COPD Medication Players by Revenue (2016-2021)
        3.1.2 Global COPD Medication Revenue Market Share by Players (2016-2021)
    3.2 Global COPD Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by COPD Medication Revenue
    3.4 Global COPD Medication Market Concentration Ratio
        3.4.1 Global COPD Medication Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by COPD Medication Revenue in 2020
    3.5 COPD Medication Key Players Head office and Area Served
    3.6 Key Players COPD Medication Product Solution and Service
    3.7 Date of Enter into COPD Medication Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 COPD Medication Breakdown Data by Type
    4.1 Global COPD Medication Historic Market Size by Type (2016-2021)
    4.2 Global COPD Medication Forecasted Market Size by Type (2022-2027)

5 COPD Medication Breakdown Data by Application
    5.1 Global COPD Medication Historic Market Size by Application (2016-2021)
    5.2 Global COPD Medication Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America COPD Medication Market Size (2016-2027)
    6.2 North America COPD Medication Market Size by Type
        6.2.1 North America COPD Medication Market Size by Type (2016-2021)
        6.2.2 North America COPD Medication Market Size by Type (2022-2027)
        6.2.3 North America COPD Medication Market Size by Type (2016-2027)
    6.3 North America COPD Medication Market Size by Application
        6.3.1 North America COPD Medication Market Size by Application (2016-2021)
        6.3.2 North America COPD Medication Market Size by Application (2022-2027)
        6.3.3 North America COPD Medication Market Size by Application (2016-2027)
    6.4 North America COPD Medication Market Size by Country
        6.4.1 North America COPD Medication Market Size by Country (2016-2021)
        6.4.2 North America COPD Medication Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe COPD Medication Market Size (2016-2027)
    7.2 Europe COPD Medication Market Size by Type
        7.2.1 Europe COPD Medication Market Size by Type (2016-2021)
        7.2.2 Europe COPD Medication Market Size by Type (2022-2027)
        7.2.3 Europe COPD Medication Market Size by Type (2016-2027)
    7.3 Europe COPD Medication Market Size by Application
        7.3.1 Europe COPD Medication Market Size by Application (2016-2021)
        7.3.2 Europe COPD Medication Market Size by Application (2022-2027)
        7.3.3 Europe COPD Medication Market Size by Application (2016-2027)
    7.4 Europe COPD Medication Market Size by Country
        7.4.1 Europe COPD Medication Market Size by Country (2016-2021)
        7.4.2 Europe COPD Medication Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific COPD Medication Market Size (2016-2027)
    8.2 Asia-Pacific COPD Medication Market Size by Type
        8.2.1 Asia-Pacific COPD Medication Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific COPD Medication Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific COPD Medication Market Size by Type (2016-2027)
    8.3 Asia-Pacific COPD Medication Market Size by Application
        8.3.1 Asia-Pacific COPD Medication Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific COPD Medication Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific COPD Medication Market Size by Application (2016-2027)
    8.4 Asia-Pacific COPD Medication Market Size by Region
        8.4.1 Asia-Pacific COPD Medication Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific COPD Medication Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America COPD Medication Market Size (2016-2027)
    9.2 Latin America COPD Medication Market Size by Type
        9.2.1 Latin America COPD Medication Market Size by Type (2016-2021)
        9.2.2 Latin America COPD Medication Market Size by Type (2022-2027)
        9.2.3 Latin America COPD Medication Market Size by Type (2016-2027)
    9.3 Latin America COPD Medication Market Size by Application
        9.3.1 Latin America COPD Medication Market Size by Application (2016-2021)
        9.3.2 Latin America COPD Medication Market Size by Application (2022-2027)
        9.3.3 Latin America COPD Medication Market Size by Application (2016-2027)
    9.4 Latin America COPD Medication Market Size by Country
        9.4.1 Latin America COPD Medication Market Size by Country (2016-2021)
        9.4.2 Latin America COPD Medication Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa COPD Medication Market Size (2016-2027)
    10.2 Middle East & Africa COPD Medication Market Size by Type
        10.2.1 Middle East & Africa COPD Medication Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa COPD Medication Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa COPD Medication Market Size by Type (2016-2027)
    10.3 Middle East & Africa COPD Medication Market Size by Application
        10.3.1 Middle East & Africa COPD Medication Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa COPD Medication Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa COPD Medication Market Size by Application (2016-2027)
    10.4 Middle East & Africa COPD Medication Market Size by Country
        10.4.1 Middle East & Africa COPD Medication Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa COPD Medication Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Roche
        11.1.1 Roche Company Details
        11.1.2 Roche Business Overview
        11.1.3 Roche COPD Medication Introduction
        11.1.4 Roche Revenue in COPD Medication Business (2016-2021)
        11.1.5 Roche Recent Development
    11.2 Novartis
        11.2.1 Novartis Company Details
        11.2.2 Novartis Business Overview
        11.2.3 Novartis COPD Medication Introduction
        11.2.4 Novartis Revenue in COPD Medication Business (2016-2021)
        11.2.5 Novartis Recent Development
    11.3 GSK
        11.3.1 GSK Company Details
        11.3.2 GSK Business Overview
        11.3.3 GSK COPD Medication Introduction
        11.3.4 GSK Revenue in COPD Medication Business (2016-2021)
        11.3.5 GSK Recent Development
    11.4 Teva
        11.4.1 Teva Company Details
        11.4.2 Teva Business Overview
        11.4.3 Teva COPD Medication Introduction
        11.4.4 Teva Revenue in COPD Medication Business (2016-2021)
        11.4.5 Teva Recent Development
    11.5 AstraZeneca
        11.5.1 AstraZeneca Company Details
        11.5.2 AstraZeneca Business Overview
        11.5.3 AstraZeneca COPD Medication Introduction
        11.5.4 AstraZeneca Revenue in COPD Medication Business (2016-2021)
        11.5.5 AstraZeneca Recent Development
    11.6 Boehringer Ingelheim
        11.6.1 Boehringer Ingelheim Company Details
        11.6.2 Boehringer Ingelheim Business Overview
        11.6.3 Boehringer Ingelheim COPD Medication Introduction
        11.6.4 Boehringer Ingelheim Revenue in COPD Medication Business (2016-2021)
        11.6.5 Boehringer Ingelheim Recent Development
    11.7 Nephron Pharmaceuticals
        11.7.1 Nephron Pharmaceuticals Company Details
        11.7.2 Nephron Pharmaceuticals Business Overview
        11.7.3 Nephron Pharmaceuticals COPD Medication Introduction
        11.7.4 Nephron Pharmaceuticals Revenue in COPD Medication Business (2016-2021)
        11.7.5 Nephron Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global COPD Medication Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Short-Acting Bronchodilator
    Table 3. Key Players of Corticosteroids
    Table 4. Key Players of Methylxanthines
    Table 5. Key Players of Long-Acting Bronchodilators
    Table 6. Key Players of Combination Drugs
    Table 7. Global COPD Medication Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global COPD Medication Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 9. Global COPD Medication Market Size by Regions (2016-2021) & (US$ Million)
    Table 10. Global COPD Medication Market Share by Regions (2016-2021)
    Table 11. Global COPD Medication Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 12. Global COPD Medication Market Share by Regions (2022-2027)
    Table 13. COPD Medication Market Trends
    Table 14. COPD Medication Market Drivers
    Table 15. COPD Medication Market Challenges
    Table 16. COPD Medication Market Restraints
    Table 17. Global COPD Medication Revenue by Players (2016-2021) & (US$ Million)
    Table 18. Global COPD Medication Market Share by Players (2016-2021)
    Table 19. Global Top COPD Medication Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in COPD Medication as of 2020)
    Table 20. Ranking of Global Top COPD Medication Companies by Revenue (US$ Million) in 2020
    Table 21. Global 5 Largest Players Market Share by COPD Medication Revenue (CR5 and HHI) & (2016-2021)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players COPD Medication Product Solution and Service
    Table 24. Date of Enter into COPD Medication Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global COPD Medication Market Size by Type (2016-2021) (US$ Million)
    Table 27. Global COPD Medication Revenue Market Share by Type (2016-2021)
    Table 28. Global COPD Medication Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 29. Global COPD Medication Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 30. Global COPD Medication Market Size Share by Application (2016-2021) & (US$ Million)
    Table 31. Global COPD Medication Revenue Market Share by Application (2016-2021)
    Table 32. Global COPD Medication Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 33. Global COPD Medication Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 34. North America COPD Medication Market Size by Type (2016-2021) (US$ Million)
    Table 35. North America COPD Medication Market Size by Type (2022-2027) & (US$ Million)
    Table 36. North America COPD Medication Market Size by Application (2016-2021) (US$ Million)
    Table 37. North America COPD Medication Market Size by Application (2022-2027) & (US$ Million)
    Table 38. North America COPD Medication Market Size by Country (2016-2021) & (US$ Million) 
    Table 39. North America COPD Medication Market Size by Country (2022-2027) & (US$ Million) 
    Table 40. Europe COPD Medication Market Size by Type (2016-2021) (US$ Million)
    Table 41. Europe COPD Medication Market Size by Type (2022-2027) & (US$ Million)
    Table 42. Europe COPD Medication Market Size by Application (2016-2021) (US$ Million)
    Table 43. Europe COPD Medication Market Size by Application (2022-2027) & (US$ Million)
    Table 44. Europe COPD Medication Market Size by Country (2016-2021) & (US$ Million) 
    Table 45. Europe COPD Medication Market Size by Country (2022-2027) & (US$ Million) 
    Table 46. Asia-Pacific COPD Medication Market Size by Type (2016-2021) (US$ Million)
    Table 47. Asia-Pacific COPD Medication Market Size by Type (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific COPD Medication Market Size by Application (2016-2021) (US$ Million)
    Table 49. Asia-Pacific COPD Medication Market Size by Application (2022-2027) & (US$ Million)
    Table 50. Asia-Pacific COPD Medication Market Size by Region (2016-2021) & (US$ Million) 
    Table 51. Asia-Pacific COPD Medication Market Size by Region (2022-2027) & (US$ Million) 
    Table 52. Latin America COPD Medication Market Size by Type (2016-2021) (US$ Million)
    Table 53. Latin America COPD Medication Market Size by Type (2022-2027) & (US$ Million)
    Table 54. Latin America COPD Medication Market Size by Application (2016-2021) (US$ Million)
    Table 55. Latin America COPD Medication Market Size by Application (2022-2027) & (US$ Million)
    Table 56. Latin America COPD Medication Market Size by Country (2016-2021) & (US$ Million) 
    Table 57. Latin America COPD Medication Market Size by Country (2022-2027) & (US$ Million) 
    Table 58. Middle East & Africa COPD Medication Market Size by Type (2016-2021) (US$ Million)
    Table 59. Middle East & Africa COPD Medication Market Size by Type (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa COPD Medication Market Size by Application (2016-2021) (US$ Million)
    Table 61. Middle East & Africa COPD Medication Market Size by Application (2022-2027) & (US$ Million)
    Table 62. Middle East & Africa COPD Medication Market Size by Country (2016-2021) & (US$ Million) 
    Table 63. Middle East & Africa COPD Medication Market Size by Country (2022-2027) & (US$ Million) 
    Table 64. Roche Company Details
    Table 65. Roche Business Overview
    Table 66. Roche COPD Medication Product
    Table 67. Roche Revenue in COPD Medication Business (2016-2021) & (US$ Million)
    Table 68. Roche Recent Development
    Table 69. Novartis Company Details
    Table 70. Novartis Business Overview
    Table 71. Novartis COPD Medication Product
    Table 72. Novartis Revenue in COPD Medication Business (2016-2021) & (US$ Million)
    Table 73. Novartis Recent Development
    Table 74. GSK Company Details
    Table 75. GSK Business Overview
    Table 76. GSK COPD Medication Product
    Table 77. GSK Revenue in COPD Medication Business (2016-2021) & (US$ Million)
    Table 78. GSK Recent Development
    Table 79. Teva Company Details
    Table 80. Teva Business Overview
    Table 81. Teva COPD Medication Product
    Table 82. Teva Revenue in COPD Medication Business (2016-2021) & (US$ Million)
    Table 83. Teva Recent Development
    Table 84. AstraZeneca Company Details
    Table 85. AstraZeneca Business Overview
    Table 86. AstraZeneca COPD Medication Product
    Table 87. AstraZeneca Revenue in COPD Medication Business (2016-2021) & (US$ Million)
    Table 88. AstraZeneca Recent Development
    Table 89. Boehringer Ingelheim Company Details
    Table 90. Boehringer Ingelheim Business Overview
    Table 91. Boehringer Ingelheim COPD Medication Product
    Table 92. Boehringer Ingelheim Revenue in COPD Medication Business (2016-2021) & (US$ Million)
    Table 93. Boehringer Ingelheim Recent Development
    Table 94. Nephron Pharmaceuticals Company Details
    Table 95. Nephron Pharmaceuticals Business Overview
    Table 96. Nephron Pharmaceuticals COPD Medication Product
    Table 97. Nephron Pharmaceuticals Revenue in COPD Medication Business (2016-2021) & (US$ Million)
    Table 98. Nephron Pharmaceuticals Recent Development
    Table 99. Research Programs/Design for This Report
    Table 100. Key Data Information from Secondary Sources
    Table 101. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global COPD Medication Market Share by Type: 2020 VS 2027
    Figure 2. Short-Acting Bronchodilator Features
    Figure 3. Corticosteroids Features
    Figure 4. Methylxanthines Features
    Figure 5. Long-Acting Bronchodilators Features
    Figure 6. Combination Drugs Features
    Figure 7. Global COPD Medication Market Share by Application: 2020 VS 2027
    Figure 8. Hospital Case Studies
    Figure 9. Clinic Case Studies
    Figure 10. Pharmacy Case Studies
    Figure 11. Online Pharmacy Case Studies
    Figure 12. COPD Medication Report Years Considered
    Figure 13. Global COPD Medication Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 14. Global COPD Medication Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 15. Global COPD Medication Market Share by Regions: 2020 VS 2027
    Figure 16. Global COPD Medication Market Share by Regions (2022-2027)
    Figure 17. Global COPD Medication Market Share by Players in 2020
    Figure 18. Global Top COPD Medication Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in COPD Medication as of 2020
    Figure 19. The Top 10 and 5 Players Market Share by COPD Medication Revenue in 2020
    Figure 20. Global COPD Medication Revenue Market Share by Type (2016-2021)
    Figure 21. Global COPD Medication Revenue Market Share by Type (2022-2027)
    Figure 22. North America COPD Medication Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. North America COPD Medication Market Share by Type (2016-2027)
    Figure 24. North America COPD Medication Market Share by Application (2016-2027)
    Figure 25. North America COPD Medication Market Share by Country (2016-2027)
    Figure 26. United States COPD Medication Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Canada COPD Medication Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. Europe COPD Medication Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. Europe COPD Medication Market Share by Type (2016-2027)
    Figure 30. Europe COPD Medication Market Share by Application (2016-2027)
    Figure 31. Europe COPD Medication Market Share by Country (2016-2027)
    Figure 32. Germany COPD Medication Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. France COPD Medication Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. U.K. COPD Medication Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Italy COPD Medication Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Russia COPD Medication Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Nordic COPD Medication Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Asia-Pacific COPD Medication Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Asia-Pacific COPD Medication Market Share by Type (2016-2027)
    Figure 40. Asia-Pacific COPD Medication Market Share by Application (2016-2027)
    Figure 41. Asia-Pacific COPD Medication Market Share by Region (2016-2027)
    Figure 42. China COPD Medication Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Japan COPD Medication Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. South Korea COPD Medication Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Southeast Asia COPD Medication Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. India COPD Medication Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Australia COPD Medication Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Latin America COPD Medication Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Latin America COPD Medication Market Share by Type (2016-2027)
    Figure 50. Latin America COPD Medication Market Share by Application (2016-2027)
    Figure 51. Latin America COPD Medication Market Share by Country (2016-2027)
    Figure 52. Mexico COPD Medication Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Brazil COPD Medication Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Middle East & Africa COPD Medication Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Middle East & Africa COPD Medication Market Share by Type (2016-2027)
    Figure 56. Middle East & Africa COPD Medication Market Share by Application (2016-2027)
    Figure 57. Middle East & Africa COPD Medication Market Share by Country (2016-2027)
    Figure 58. Turkey COPD Medication Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. Saudi Arabia COPD Medication Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 60. UAE COPD Medication Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 61. Roche Revenue Growth Rate in COPD Medication Business (2016-2021)
    Figure 62. Novartis Revenue Growth Rate in COPD Medication Business (2016-2021)
    Figure 63. GSK Revenue Growth Rate in COPD Medication Business (2016-2021)
    Figure 64. Teva Revenue Growth Rate in COPD Medication Business (2016-2021)
    Figure 65. AstraZeneca Revenue Growth Rate in COPD Medication Business (2016-2021)
    Figure 66. Boehringer Ingelheim Revenue Growth Rate in COPD Medication Business (2016-2021)
    Figure 67. Nephron Pharmaceuticals Revenue Growth Rate in COPD Medication Business (2016-2021)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Roche
Novartis
GSK
Teva
AstraZeneca
Boehringer Ingelheim
Nephron Pharmaceuticals
Frequently Asked Questions
COPD Medication report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
COPD Medication report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
COPD Medication report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports